Impact of apolipoprotein E genotype and dietary quercetin on paraoxonase 1 status in apoE3 and apoE4 transgenic mice

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 110-113

  Boesch Saadatmandi, Christine ^a   Niering, Julia ^a   Minihane, Anne Marie ^b   Wiswedel, Ingrid ^c   Gardeman, Andreas ^c   Wolffram, Siegfried ^a   Rimbach, Gerald ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

ApoE genotype; Inflammation; Paraoxonase 1; Quercetin

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ARYLDIALKYLPHOSPHATASE 1; BETA GLUCURONIDASE; MESSENGER RNA; QUERCETIN; SULFATASE; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SERUM AMYLOID P;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONJUGATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM;

ANIMALS; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; DIETARY SUPPLEMENTS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; LIVER; MICE; MICE, TRANSGENIC; PPAR GAMMA; QUERCETIN; RNA, MESSENGER; SERUM AMYLOID P-COMPONENT;

EID: 77954312932     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.027     Document Type: Article

References (15)

1. Jofre-Monseny L., Minihane A.M., Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol Nutr Food Res 2008, 52:131-145.
2. Aviram M., Rosenblat M., Bisgaier C.L., et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 1998, 101:1581-1590.
3. Shih D.M., Gu L., Xia Y.R., et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998, 394:284-287.
4. She Z.G., Zheng W., Wei Y.S., et al. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice. Circ Res 2009, 104:1160-1168.
5. Gong M., Garige M., Varatharajalu R., et al. Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun 2009, 379:1001-1004.
6. Gaedicke S., Zhang X., Huebbe P., et al. Dietary vitamin E, brain redox status and expression of Alzheimer's disease-relevant genes in rats. Br J Nutr 2009, 102:398-406.
7. Bieger J., Cermak R., Blank R., et al. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J Nutr 2008, 138:1417-1420.
8. Ng C.J., Shih D.M., Hama S.Y., et al. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 2005, 38:153-163.
9. Dietrich M., Hu Y., Block G., et al. Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 2005, 40:329-334.
10. Mackness B., Hine D., McElduff P., Mackness M. High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease. Atherosclerosis 2006, 186:396-401.
11. Boesch-Saadatmandi C., Wolffram S., Minihane A.M., Rimbach G. Effect of apoE genotype and dietary quercetin on blood lipids and TNF-alpha levels in apoE3 and apoE4 targeted gene replacement mice. Br J Nutr 2009, 101:1440-1443.
12. Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis 2009, 202:431-438.
13. Khateeb J., Gantman A., Kreitenberg A.J., Aviram M., Fuhrman B. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis 2010, 208:119-125.
14. Arbones-Mainar J.M., Johnson L.A., Altenburg M.K., Maeda N. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int J Obes (Lond) 2008, 32:1595-1605.
15. Roses A.D., Saunders A.M., Huang Y., et al. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). Pharmacogenom J 2007, 7:10-28.